Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5878546 | The American Journal of Medicine | 2013 | 5 Pages |
Abstract
Guideline adherence restricts ceruloplasmin use to a population with a higher pre-test probability of Wilson disease: patients with chronic liver disease aged 3 to 55 years who have been tested for common causes of liver disease. The majority of the serum ceruloplasmin was measured in patients not indicated by the guidelines, resulting in poor test performance and wasted healthcare resources. Our data on ceruloplasmin use could serve as a touchstone for broader discussions on rational clinical decision making.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Elliot B. MD, David O. MD, Ramy MD, DPhil, Michelle MD, MPH,